Cargando…
Sustainability of C-Reactive Protein Apheresis in Acute Myocardial Infarction—Results from a Supplementary Data Analysis of the Exploratory C-Reactive Protein in Acute Myocardial Infarction-1 Study
In the multicenter, non-randomized, exploratory C-reactive protein (CRP) Apheresis in Myocardial Infarction (CAMI-1) study, CRP apheresis after ST-Elevation Myocardial Infarction (STEMI) significantly decreased blood CRP concentrations in humans. Cardiac damage was assessed by Cardiac Magnetic Reson...
Autores principales: | Skarabis, Horst, Torzewski, Jan, Ries, Wolfgang, Heigl, Franz, Garlichs, Christoph D., Kunze, Rudolf, Sheriff, Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655548/ https://www.ncbi.nlm.nih.gov/pubmed/36362673 http://dx.doi.org/10.3390/jcm11216446 |
Ejemplares similares
-
C-Reactive Protein Apheresis as Anti-inflammatory Therapy in Acute Myocardial Infarction: Results of the CAMI-1 Study
por: Ries, Wolfgang, et al.
Publicado: (2021) -
“First in Man”: Case Report of Selective C-Reactive Protein Apheresis in a Patient with Acute ST Segment Elevation Myocardial Infarction
por: Ries, Wolfgang, et al.
Publicado: (2018) -
Targeting C-Reactive Protein by Selective Apheresis in Humans: Pros and Cons
por: Torzewski, Jan, et al.
Publicado: (2022) -
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV) Registry
por: Schumann, Christian, et al.
Publicado: (2022) -
Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis
por: Torzewski, Jan, et al.
Publicado: (2021)